Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
transcription factor 21 | 0.537 | 0.692 | 0.83 |
|
disease | 0.500 | None | 0.933 | 2 | 1 | 2011 | 2020 | ||||||||
|
phosphatase and actin regulator 1 | 0.663 | 0.423 | 0.64 |
|
disease | 0.500 | None | 1.000 | 2 | 2 | 2011 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2B | 0.417 | 0.769 | 7.3E-03 |
|
disease | 0.500 | None | 1.000 | 1 | 1 | 2008 | 2019 | ||||||||
|
lipoprotein(a) | 0.444 | 0.769 | 6.6E-89 |
|
disease | 0.500 | None | 0.958 | 1 | 2 | 1988 | 2019 | ||||||||
|
phospholipid phosphatase 3 | 0.722 | 0.192 | 0.92 |
|
disease | 0.490 | None | 1.000 | 2 | 1 | 2011 | 2019 | ||||||||
|
junctional cadherin 5 associated | 0.751 | 0.269 | 3.0E-03 |
|
disease | 0.470 | None | 1.000 | 1 | 1 | 2011 | 2019 | ||||||||
|
SH2B adaptor protein 3 | 0.527 | 0.692 | 1.0E-04 |
|
disease | 0.460 | None | 1.000 | 2 | 1 | 2011 | 2018 | ||||||||
|
zinc finger C3HC-type containing 1 | 0.760 | 0.308 | 2.6E-04 |
|
disease | 0.460 | None | 1.000 | 1 | 1 | 2011 | 2019 | ||||||||
|
muscle RAS oncogene homolog | 0.590 | 0.731 | 0.92 |
|
disease | 0.450 | None | 0.900 | 2 | 2 | 2009 | 2019 | ||||||||
|
guanylate cyclase 1 soluble subunit alpha 1 | 0.686 | 0.577 | 3.1E-08 |
|
disease | 0.450 | None | 1.000 | 1 | 1 | 2012 | 2019 | ||||||||
|
ATP binding cassette subfamily G member 8 | 0.573 | 0.538 | 2.4E-20 |
|
disease | 0.450 | None | 1.000 | 1 | 1 | 2000 | 2018 | ||||||||
|
WD repeat domain 12 | 0.769 | 0.192 | 3.3E-04 |
|
disease | 0.410 | None | 1.000 | 1 | 1 | 2011 | 2018 | ||||||||
|
HHIP like 1 | 0.805 | 0.077 | 2.4E-06 |
|
disease | 0.410 | None | 1.000 | 1 | 1 | 2011 | 2019 | ||||||||
|
protein C receptor | 0.560 | 0.692 | 5.6E-03 |
|
disease | 0.400 | None | 1.000 | 1 | 1 | 2013 | 2018 | ||||||||
|
CDKN2B antisense RNA 1 | 0.491 | 0.769 |
|
disease | 0.200 | None | 0.978 | 3 | 23 | 2007 | 2019 | |||||||||
|
lipoprotein lipase | 0.474 | 0.808 | 1.3E-09 |
|
disease | 0.200 | None | 0.918 | 2 | 1 | 1993 | 2020 | ||||||||
|
interleukin 6 receptor | 0.471 | 0.846 | 3.2E-05 |
|
disease | 0.200 | None | 1.000 | 1 | 1 | 2009 | 2018 | ||||||||
|
plasminogen | 0.389 | 0.923 | 1.0E-02 |
|
disease | 0.200 | None | 1.000 | 1 | 1 | 1996 | 2019 | ||||||||
|
scavenger receptor class B member 1 | 0.559 | 0.731 | 6.6E-02 |
|
disease | 0.190 | None | 1.000 | 1 | 1 | 2003 | 2018 | ||||||||
|
solute carrier family 22 member 3 | 0.531 | 0.846 | 7.8E-10 |
|
disease | 0.160 | None | 1.000 | 3 | 1 | 2009 | 2017 | ||||||||
|
lipoprotein(a) like 2, pseudogene | 0.626 | 0.731 |
|
disease | 0.150 | None | 1.000 | 1 | 1 | 2009 | 2018 | |||||||||
|
fms related receptor tyrosine kinase 1 | 0.419 | 0.846 | 1.00 |
|
disease | 0.150 | None | 0.875 | 1 | 1 | 2011 | 2019 | ||||||||
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 | 0.450 | 0.885 | 1.00 |
|
disease | 0.140 | None | 0.875 | 1 | 1 | 2010 | 2018 | ||||||||
|
histone deacetylase 9 | 0.439 | 0.846 | 1.00 |
|
disease | 0.140 | None | 1.000 | 1 | 1 | 2013 | 2019 | ||||||||
|
collagen type IV alpha 1 chain | 0.484 | 0.731 | 1.00 |
|
disease | 0.140 | None | 1.000 | 1 | 3 | 2011 | 2018 |